Diagnostics Solutions Strategic Priorities slide image

Diagnostics Solutions Strategic Priorities

Molecular Diagnostics respiratory multiplex panel Breaking the barriers of syndromic testing TAGS¹ Empowered by TAGS 5 channels = 15 targets ** Channel 1 * 渤 ex Channel 2 Channel 3 Channel 4 Channel 5 Respiratory Panels Timeline (launch timing per year is illustrative): • High unmet medical need: differential diagnosis between viruses • Cost-efficient approach • Fully automated high throughput • Roche Utilizes the cobas® 6800/8800 install base 2020 SARS-CoV-2, Influenza A, Influenza B (3-plex) HMPV, Advenovirus, Entero/Rhinovirus Paraflu 1, Paraflu 2, 2021 (3-plex) Paraflu 3, Influenza A, Influenza B, RSV 2023 (3-plex) 1 TAGS: Temperature Activated Generation of Signal; 2 Common cold coronaviruses including HKU1, OC43, NL63, 229E Paraflu 4 (4-plex) Influenza A, Influenza B, RSV, HMPV, Adenovirus, Entero/Rhinovirus, Paraflu 1, Paraflu 2, Paraflu 3, Paraflu 4, SARS-COV-2, Coronavirus2 (12-plex) 52
View entire presentation